<!DOCTYPE html>
<html>
    <head>
        <title>Processa Pharmaceuticals, Inc. General form of registration statement for all companies including face-amount certificate companies</title>
        <link href="https://ir.stockpr.com/processapharmaceuticals/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css">
        <script type="text/javascript" src="https://ir.stockpr.com/javascripts/ir.js"></script>
        <link rel="stylesheet" type="text/css" href="https://ir.stockpr.com/stylesheets/xbrl.css">
        <script type="text/javascript" src="https://d1io3yog0oux5.cloudfront.net/_a67d450d2acc59dd775509682ce34f1e/processapharmaceuticals/files/theme/js/aside/ir/_js/all.js"></script>
    </head>
    <body>
        <div class="xbrl-content">
            <h3>General form of registration statement for all companies including face-amount certificate companies</h3>
            <div id="xbrl-menu-top">
                <div class="navigation">
                    <ul class="xbrl-sf-menu">
                        
                            <li>
                                <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1072">Cover</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1072">Document and Entity Information</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1076">Financial Statements</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1076">Condensed Consolidated Balance Sheets</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1077">Condensed Consolidated Balance Sheets (Parenthetical)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1078">Condensed Consolidated Statements of Operations</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1079">Condensed Consolidated Statements of Changes in Stockholders&#039; Equity</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1080">Condensed Consolidated Statements of Changes in Stockholders&#039; Equity (Parenthetical)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1081">Condensed Consolidated Statements of Cash Flows</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1082">Condensed Consolidated Statements of Cash Flows (Parenthetical)</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1083">Notes to Financial Statements</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1083">Organization and Summary of Significant Accounting Policies</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1084">Organization and Description of the Business</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1085">Going Concern and Management&#039;s Plans</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1086">Basis of Presentation and Summary of Significant Accounting Policies</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1087">Acquisition</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1088">Intangible Assets</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1089">License Agreement for PCS100</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1090">Notes Payable</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1091">Income Taxes</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1092">Stock-based Compensation</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1093">2019 Senior 8% Convertible Notes Payable</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1094">Related Party Line of Credit Agreements</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1095">Paycheck Protection Program Loan</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1096">Stockholders&#039; Equity</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1097">Net Loss Per Share of Common Stock</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1098">Leases</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1099">License Agreement with Aposense, Ltd.</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1100">Related Party Transactions</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1101">Commitments and Contingencies</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1102">Concentration of Credit Risk</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1103">Accounting Policies</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1103">Organization and Summary of Significant Accounting Policies (Policies)</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item " href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1104">Notes Tables</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1104">Acquisition (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1105">Intangible Assets (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1106">Notes Payable (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1112">Income Taxes (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1114">Stock-based Compensation (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1115">Leases (Tables)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1117">Net Loss Per Share of Common Stock (Tables)</a></li>
                                                                    </ul>
                            </li>
                                                    <li>
                                <a class="menu-item current" href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1118">Notes Details</a>
                                <ul class="submenu">
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1118">Organization and Summary of Significant Accounting Policies (Details Narrative)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1120">Going Concern and Management&#039;s Plans (Details Narrative) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1121">Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1122">Acquisition (Details Narrative) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1123">Acquisition - Schedule of Identifiable Assets and Liabilities (Details) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1124">Intangible Assets (Details Narrative)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1125">Intangible Assets (Details Narrative) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1126">Intangible Assets - Summary of Intangible Assets (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1127">Intangible Assets - Summary of Intangible Assets (Details) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1128">License Agreement for PCS100 (Details Narrative) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1129">Notes Payable (Details Narrative) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1130">Notes Payable - Schedule of Senior Convertible Notes (Details) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1131">Income Taxes (Details Narrative)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1132">Income Taxes (Details Narrative) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1133">Income Taxes - Schedule of Provision for Income Taxes (Details) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1135">Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1136">Income Taxes - Schedule of Deferred Tax Assets (Details) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1137">Stock-based Compensation (Details Narrative)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1139">Stock-based Compensation (Details Narrative) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1147">Stock-based Compensation - Schedule of Allocation of Stock-based Compensation Expense (Details) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1148">Stock-based Compensation - Schedule of Stock Option Valuation Assumption (Details) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1149">Stock-based Compensation - Schedule of Stock Option (Details) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1150">2019 Senior 8% Convertible Notes Payable (Details Narrative)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1151">Related Party Line of Credit Agreements (Details Narrative)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1152">Paycheck Protection Program Loan (Details Narrative)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1153">Stockholders&#039; Equity (Details Narrative)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1154">Stockholders&#039; Equity (Details Narrative) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1155">Net Loss Per Share of Common Stock (Details Narrative) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1156">Net Loss Per Share of Common Stock - Schedule of Net Loss Per Share Basic and Diluted (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1157">Net Loss Per Share of Common Stock - Schedule of Net Loss Per Share Basic and Diluted (Details) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1158">Net Loss Per Share of Common Stock - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1159">Net Loss Per Share of Common Stock - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1160">Leases (Details Narrative)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1161">Leases (Details Narrative) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1163">Leases - Schedule of Weighted Average Remaining Lease Terms and Discount Rate for Operating Leases (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1164">Leases - Schedule of Weighted Average Remaining Lease Terms and Discount Rate for Operating Leases (Details) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1165">Leases - Schedule of Maturities of Lease Liabilities for All Operating Leases (Details)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1166">Leases - Schedule of Maturities of Lease Liabilities for All Operating Leases (Details) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1167">License Agreement with Aposense, Ltd. (Details Narrative)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1168">Related Party Transactions (Details Narrative)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1170">Related Party Transactions (Details Narrative) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1171">Commitments and Contingencies (Details Narrative)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1172">Commitments and Contingencies (Details Narrative) (10-K)</a></li>
                                                                            <li><a href="/investors/sec-filings/all-sec-filings/xbrl_doc_only/1173">Concentration of Credit Risk (Details Narrative) (10-K)</a></li>
                                                                    </ul>
                            </li>
                                            </ul>
                </div>
            </div>
            <div class="spr-xbrl-document">
                <h4>Acquisition - Schedule of Identifiable Assets and Liabilities (Details) (10-K)</h4>
                                <div style="clear:both;"></div>
            </div>
        </div>
    </body>
</html>